Andrew Howden
Chief Executive Officer
As the CEO of iNova Pharmaceuticals and Managing Director, Andrew brings to iNova a broad experience base with more than twenty five years in the pharmaceutical industry in Australia, Asia and Europe. This includes his work at international pharmaceutical companies AstraZeneca, Astra and Upjohn, and with Quintiles and IMS Health.
Andrew joined iNova from IMS Health in September 2008, where he was President of the Asia Pacific region, based in Singapore. He was responsible for overseeing the growth of IMS data and services in all Asia Pacific markets and contributing to regional and global projects for the company.
Prior to joining IMS Andrew was Regional Vice President for AstraZeneca Asia Pacific, overseeing development of all AstraZeneca operations in Asia Pacific, including China, Korea, Taiwan, South East Asia, India, Australia & South Africa.
Andrew moved into business management in 1987, having started his career as a sales representative, after which he held significant responsibilities at the national and international level in Asia and Europe. He has lived and worked in Singapore, the UK & Sweden.
Andrew holds a Bachelor of Science Degree and Masters of Commerce from the University of New South Wales.